secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001193125-25-241639
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint raises ~$150M in public offering to fund DURAVYU clinical development
------------------------------------------------------------------------------

- Pricing: 11M shares at $12.00 each; 1.5M pre-funded warrants at $11.999 each.
- Gross proceeds ~$150M; net proceeds after underwriting discounts ~$141M.
- Net proceeds to advance DURAVYU for wet AMD and DME, plus pipeline and general purposes.
- Underwriters have 30-day option for up to 1,875,000 additional shares at $12.00.
- Offering closed on October 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000119312525241639/0001193125-25-241639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000119312525241639/d98837d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-241639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer